bioAffinity Technologies, Inc. (BIAF)
2.15
+0.22
(+11.40%)
USD |
NASDAQ |
Nov 18, 16:00
2.08
-0.07
(-3.26%)
After-Hours: 20:00
bioAffinity Technologies Total Assets (Quarterly) : 7.554M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.554M |
| June 30, 2026 | 7.619M |
| March 31, 2026 | 7.945M |
| December 31, 2025 | 10.96M |
| September 30, 2025 | 11.55M |
| June 30, 2025 | 4.751M |
| March 31, 2025 | 5.547M |
| December 31, 2024 | 6.514M |
| September 30, 2024 | 6.552M |
| June 30, 2024 | 6.656M |
| March 31, 2024 | 8.049M |
| December 31, 2023 | 8.222M |
| Date | Value |
|---|---|
| September 30, 2023 | 10.19M |
| June 30, 2023 | 8.874M |
| March 31, 2023 | 10.46M |
| December 31, 2022 | 12.18M |
| September 30, 2022 | 14.06M |
| June 30, 2022 | 0.9407M |
| March 31, 2022 | 1.353M |
| December 31, 2021 | 1.453M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.1456M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 189.60M |
| Perspective Therapeutics, Inc. | 365.68M |
| MiMedx Group, Inc. | 264.55M |
| Veracyte, Inc. | 1.573B |
| T2 Biosystems, Inc. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.639M |
| Shareholders Equity (Quarterly) | 3.915M |
| Debt to Equity Ratio | 0.3827 |
| Current Ratio | 1.511 |
| Net Debt Paydown Yield | -2.16% |